Market Research Report
Global Markets for Membrane Technology for Pharmaceuticals
|Published by||BCC Research||Product code||245634|
|Published||Content info||137 Pages
|Global Markets for Membrane Technology for Pharmaceuticals|
|Published: June 27, 2012||Content info: 137 Pages||
The global market for membrane technology reached $5.4 billion in 2010, $6.4 billion in 2011, and is forecast to surpass $10 billion in 2016 increasing at a compound annual growth rate (CAGR) of 9.3%.
The pharmaceutical market was $2.3 billion in 2010 and $2.7 billion in 2011. It is expected to grow to $4.4 billion in 2016, a CAGR of 9.9% between 2011 and 2016.
The life science laboratory market reached $1.6 billion in 2010 and $1.8 billion in 2011. The market is expected to reach $2.5 billion by 2016, a CAGR of 6.5%.
GLOBAL MARKET FOR MEMBRANE TECHNOLOGY, 2011 AND 2016 (%)
Source: BCC Research
Membrane technology is used in all phases of the pharmaceutical development processes, from laboratory research to large-scale pharmaceutical manufacturing. Applications include lab-scale DNA and protein separation and analysis, sample preparation, drug screening, cell culturing and examination, laboratory and process water purification, virus removal, and bench-, pilot-, and production-scale drug manufacturing.
Substantial changes in the pharmaceutical and biopharmaceutical industries have made membrane separations processes an important part of the production of drugs. Membrane separation processes help ensure safety and efficacy of drugs by eliminating contaminants from the laboratory through large-scale production.
This study is an update of a previous report from 2005; it combines bio-pharmaceutical, life science research, and pharmaceutical membrane separation technologies.
This report provides an in-depth analysis of the market for membrane technology in pharmaceuticals, life sciences, and biopharmaceutical applications. Areas in the report include laboratory analysis (e.g., gene and protein analysis, drug candidate screening, laboratory separations and water treatment), biopharmaceutical development (e.g., cell culturing, protein purification, virus removal) and pharmaceutical manufacturing.
Technical and market drivers are considered in evaluating the current value of the technologies and in projecting growth and trends over the next five years. Conclusions are illustrated with statistical information on markets, applications, industry structure and dynamics, and technological developments.
In addition to coverage of membrane technology by type, the report will segment the market by region, including the Americas (U.S., Canada, Latin America, South America); Europe, Middle East, Russia, and Africa (EMRA); and Asia (Japan, Australia/New Zealand, India, China, other Asia-Pacific areas).
The study is intended for individuals requiring an in-depth analysis of the life science, pharmaceutical, and biopharmaceutical membrane separation technology industries. It traces significant developments and forecasts important trends, quantifies the various market sectors, and highlights companies active in those areas.
The report will not cover membranes used in the healthcare or medical diagnostics fields, or membranes used in air and gas venting on medical devices.
Peggy S Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked in the publishing industry for both for-profit and not-for-profit organizations, and she has completed more than 20 reports for BCC.